Hairgro MF Solution is a topical formulation containing Minoxidil (5% w/v) and Finasteride (0.1% w/v), indicated for the treatment of androgenetic alopecia in both men and women. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular size and prolonging the anagen phase of the hair cycle, thereby increasing hair density and thickness. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor implicated in hair follicle miniaturization and progressive hair loss. The combined action of these active ingredients addresses hair thinning through dual mechanisms: stimulating new hair growth and preventing further follicular damage. Hairgro MF Solution is applied topically to the affected scalp areas once daily, ensuring localized delivery with minimal systemic absorption. Clinical studies have demonstrated its efficacy in halting hair loss progression and improving hair count and quality over a treatment period of several months. Patients should adhere to the recommended dosage and consult healthcare professionals prior to use, especially in cases of hypersensitivity, scalp infections, or underlying medical conditions. Adverse effects may include scalp irritation, pruritus, or transient hypertrichosis. Regular monitoring is advised to assess therapeutic response and tolerability.